Bevacizumab (Avastin) is a humanized monoclonal antibody that is approved by the U.S. Food and Drug Administration for the treatment of patients with colon cancer, lung cancer, glioblastoma, renal-cell carcinoma, and age-related macular degeneration. As
Clonality:
Monoclonal
Clone Designation:
[46E3]
Purity:
Protein A chromatography
Form:
Purified
Antibody Type:
Monoclonal Antibody
Application Dilute:
ELISA detection: 0.01-0.05 µg/ml
* VAT and and shipping costs not included. Errors and price changes excepted